Gates Institute is committed to moving regenerative medicine technologies from the laboratory and into the clinic and commercialization.To further this goal, the Institute provides:
(1) an Entrepreneur in Residence dedicated to advancing technologies to the clinic,
(2) translational funding through the Grubstake Award designed to advancing technologies through the FDA approval process,
(3) business development, financial planning, corporate formation, and intellectual property support through the Startup Toolbox program, and
(4) technology development support through the Gates Biomanufacturing Facility, a certified GMP (good manufacturing practice) facility for cell and protein therapeutics.
The Gates Institute Entrepreneur in Residence works in collaboration with CU Innovations to identify and develop regenerative medicine inventions for translation into clinical use and commercialization. Gates Institute has a robust pipeline of technologies in development from newly discovered inventions to those in clinical trials or licensed to companies.